The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York PDF) Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling